Boeing vs. Joby Aviation: Which Airplane Manufacturing Stock Promises High-Flying Profits?

Boeing is cited as having returned to profitability with FY2025 revenue of ~$89.5B (+34.5% YoY) and net income of ~$2.2B (net margin ~2.5%), but free cash flow remains deeply negative at ~$-1.9B (inflated by SBC ~40% of operating cash flow). The article contrasts this with Joby Aviation’s rapid scaling—FY2025 revenue ~ $53.4M vs ~$136k in 2024—while still posting a large net loss (~$-930M) and negative FCF (~$-563.8M), as eVTOL certification and FAA/production approvals remain key hurdles. Overall, it frames Boeing as a recovering, more essential and valuation-supported bet, while Joby is positioned as a higher-risk, speculative upside play for urban air mobility.

Analysis

Boeing is still a balance-sheet repair story disguised as an earnings recovery. The key market mechanism is that incremental operating improvement may be largely trapped by debt service, capex, and working-capital needs, so the equity can look optically cheap while staying stubbornly range-bound unless free cash flow turns sustainably positive. If production normalizes, the second-order winners are the industrial suppliers and airlines that need fleet refresh capacity; the loser is any competitor relying on Boeing execution failures to hold share.

Joby is the cleaner equity structure, but it remains a financing-optionality trade, not a cash-flow trade. The upside path is a slow re-rating as certification milestones reduce perceived dilution risk; the downside is binary delay risk, where one FAA slip or a higher burn rate can reset the timeline and compress the multiple quickly. The real competitive threat is not just Archer, but the broader reality that only one or two eVTOL names will likely survive to scale, so the market may be overestimating the terminal share of today’s public winners.

Contrarian view: consensus is treating Boeing as the safer “real business” and Joby as pure speculation, but that framing misses duration. Boeing’s equity can be more fragile if production recovery stalls, because leverage leaves little margin for error, while Joby’s debt-free balance sheet gives it time to absorb delays. The cleaner falsifiers are simple: Boeing losing cash again as output ramps, or Joby needing an early capital raise before FAA certification milestones are de-risked.

Key Decisions for Investors

• Prefer a relative-value long BA / short ACHR basket for 1-3 months only if you want to express 'industrial recovery over pre-revenue dilution risk'; cut the long if BA cash flow guide turns negative again or if 737/777X schedule slippage reappears.
• Avoid outright long JOBY here; wait for a pullback or a concrete certification milestone. If entering, use a small call spread rather than stock to define downside, because the main risk is timeline delay, not insolvency.
• Watch BA on quarterly free-cash-flow conversion and debt reduction, not headline revenue. If FCF stays negative despite higher output, the stock should be treated as a fade into strength rather than a durable re-rating candidate.
• For investors wanting a cleaner second-order beneficiary, favor suppliers/airframe-exposed peers only on proof of sustained Boeing throughput; otherwise the trade is too dependent on execution optimism rather than independently verifiable demand.